Waldmann disease

Waldmann disease, also known as Primary Intestinal Lymphangiectasia (PIL), is a rare disease characterized by enlargement of the lymph vessels supplying the lamina propria of the small intestine.

Uses your system voice; voice and rate in settings.

Snapshot

≈ 2 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Waldmann disease, also known as Primary Intestinal Lymphangiectasia (PIL), is a rare disease characterized by enlargement of the lymph vessels supplying the lamina propria of the small intestine. Although its prevalence is unknown, it being classified as a "rare disease" means that less than 200,000 of the population of the United States are affected by this condition and its subtypes and there have been approximately 50 reported cases of adult-onset PIL since 1961.

Signs and symptoms

Signs and symptoms of the disease include diarrhea, nausea, swelling of the legs, protein-losing enteropathy, immunodeficiency and loss of lymphatic fluid into the intestines. It is usually diagnosed before the patient is 3 years old, but it is sometimes diagnosed in adults.

Diagnosis

The disease is diagnosed by doing a biopsy of the affected area. Severity of the disease is then determined by measuring alpha 1 -antitrypsin proteins in a stool sample.

Management

Once the main cause of the disease is treated, a diet of low-fat and high-protein aliments, supplemental calcium and certain vitamins has been shown to reduce symptom effects. Adding medium-chain triglycerides (MCTs) to the diet allows for increased caloric intake while adhering to dietary restrictions, helping to manage symptoms such as diarrhea and steatorrhea and promoting growth in affected individuals.

This diet, however, is not a cure. If the diet is stopped, the symptoms will eventually reappear. Medication is also used to treat this disease, including octreotide, sirolimus, anti-plasmin and, at least in one case, trametinib.

History

The disease was first reported in 1961 by T. A. Waldmann. He described 18 cases of patients having a low level 131 I-albumin. Biopsies of the small intestine were examined under the microscope and found various levels of dilatation of the lymph vessels.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1338157187 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

5 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.